LIFE SCIENCES & GENOMICS
CASE 1: Precision Oncology, AI Use Cases Fast-Tracked in 30 Days
Situation: A publicly traded precision oncology company specializing in advanced genomics had identified AI as a strategic priority but could not move use cases from proposal to approval. Without a shared governance language across scientific, clinical, and executive functions, every AI initiative stalled at the committee level. The company was spending on AI licenses and seeing no ROI.
What Global Data Innovation Did: Trained the full senior leadership team on the TRUST framework, creating a unified triage protocol to distinguish high-ROI, lower-risk AI use cases from those requiring extended review. Established a clear escalation structure so the right decisions reached the right level, and the rest moved fast.
Outcome: Within 30 days of training, AI use cases were identified, approved, and fast-tracked. Initiatives included AI-assisted genomic lab result tracking and AI-powered insurance claim challenges, two areas with direct impact on both patient outcomes and revenue cycle performance. Two years of AI gridlock ended in one month.
CASE 2: Activist Threat Abated, 21% Growth Followed
Situation: A U.S. public company in the non-opioid pain treatment sector was facing an activist investor campaign. Among the vulnerabilities the activist cited: cyber weaknesses and AI governance gaps that created material exposure ahead of upcoming product launches. The board had no defensible governance posture to present to institutional investors.
What Global Data Innovation Did: Advised the board and senior leadership on cyber and AI governance, building a documented, defensible governance structure that demonstrated operational strength and board-level readiness to both institutional investors and the activist.
Outcome: The activist threat abated. The company achieved 21% year-over-year growth. The governance work became the foundation for responsible AI deployment ahead of new product launches turning a vulnerability into a competitive differentiator.
Note for Genomics and Biotech Audiences: Genomic identifiers are increasingly treated as biometric data under BIPA and emerging state laws, the same legal exposure that has cost other companies consent decrees and eight-figure fines in every jurisdiction where they operated. Global Data Innovation has a documented track record of preventing that outcome. If your company collects, processes, or commercializes genomic data, this is not a future risk. It is a present one.
BIOPHARMA & CLINICAL RESEARCH
CASE 3: FDA Approval Acceleration and Cross-Border Clinical Trial Compliance
Situation: A global biopharmaceutical company pioneering breakthrough treatments in oncology, HIV, and inflammatory conditions needed privacy and AI governance for cross-border clinical trials. Regulatory barriers to international trial expansion and AI-assisted drug discovery were creating material delays to both patient access and revenue. Every quarter of delay on a major indication represents hundreds of millions in foregone revenue.
What Global Data Innovation Did: Built a HIPAA-compliant AI governance framework for clinical research and patient data. Established cross-border data transfer protocols aligned to FDA and international health authority requirements. Developed an AI ethics framework for drug discovery that enabled rapid deployment without triggering regulatory review delays.
Outcome: AI-assisted drug discovery accelerated FDA approvals and international clinical trial expansion. The governance framework supported $3 billion in operating cash flow and a treatment that demonstrated 100% efficacy in its indication. Zero compliance violations across all clinical data management. The governance investment paid for itself in the first approval cycle.
CASE 4: Precision Health Platform, $1.7B in Investment Enabled Through Governance
Situation: A precision health technology company serving global life sciences organizations, major health systems, and clinical research institutions needed comprehensive privacy, cybersecurity, and AI governance frameworks. Strategic pharma partnerships and health system relationships were at risk without a governance foundation those partners could trust and verify. No governance, no deal.
What Global Data Innovation Did: Led strategic advisory on privacy, cybersecurity, and AI governance for biomedical research platforms. Established clinical research data protection protocols, AI model security frameworks, and HIPAA-compliant health data governance structures that could withstand pharma partner due diligence and health system procurement review.
Outcome: The governance framework enabled $1.7B+ in strategic investment. Pharma partnerships with four major global pharmaceutical companies were established and secured. The platform expanded to serve three of the leading academic health systems in the country. A rapid-response health platform was deployed at massive scale during a national health emergency, operating under full privacy and compliance safeguards — because the governance foundation was already in place.
FINANCIAL SERVICES
CASE 5: GenAI Deployed to 30,000+ Developers, $11.8B Modernization Unlocked
Situation: One of the world's largest multinational banks, serving over 200 million customer accounts across 160+ countries, needed AI risk governance alignment, privacy-by-design implementation, and embedded controls across emerging generative AI platforms. Without governance infrastructure, the bank could not deploy GenAI at enterprise scale, and its competitors were moving faster.
What Global Data Innovation Did: Provided legal advisory and governance support to integrate privacy and compliance into enterprise-wide AI deployment. Built cross-functional governance structures and GenAI platform controls that enabled deployment without creating regulatory exposure.
Outcome: The bank deployed generative AI tools to over 30,000 developers, fueling an $11.8 billion technology modernization initiative. The bank's own research projected that AI governance at scale could boost total banking industry profits by 9%, or $170 billion, by 2028. Governance was not the brake. It was the accelerant.
CASE 6: Record Financial Performance After Board Cyber Assessment
Situation: A top-10 U.S. commercial property and casualty insurer with $10.8B+ in annual revenue needed a comprehensive board-level cyber assessment to improve risk posture and establish readiness for AI advancement. The board knew its cyber governance was not where it needed to be. The question was how exposed they were and what to do about it before an incident forced the answer.
What Global Data Innovation’s Founder Did Prior to Starting the Company: Conducted a comprehensive cyber assessment for the board in partnership with a former senior regulator, covering board-level cybersecurity governance, enterprise-wide vulnerability assessment, AI readiness evaluation, and regulatory compliance alignment. Delivered findings and a prioritized remediation roadmap the board could act on immediately.
Outcome: The company delivered record core income of $1.316 billion for full year 2024, with 16 consecutive quarters of underlying combined ratio below 92%. AM Best and Moody's both upgraded their outlook from stable to positive, directly citing improved risk management capabilities. New business reached a record high of $2.3 billion. The board approved a 5% dividend increase plus a special dividend. The cyber assessment paid for itself many times over before the year was out.
RETAIL
CASE 7: AI Paralysis Resolved, 2+ Years of Gridlock Ended in One Engagement
Situation: A leading fashion retailer operating 1,000 + locations had been attempting to implement AI governance for over two years. Less than 2% of its AI governance plans were complete. Use case approval was bottlenecked at committee level, spend was bloated across initiatives that could not get approved, and the organization was visibly missing investor expectations on AI ROI. The board was asking questions management could not answer.
What Global Data Innovation Did: Advised on comprehensive TRUST framework implementation, including governance structure design, high-impact use case identification, and a strategic AI roadmap that gave management a clear path from paralysis to deployment. Identified which initiatives to fast-track, which to pause, and which to kill.
Outcome: AI paralysis resolved. High-impact AI use cases were identified, approved, and moving within the engagement. In the quarter following implementation, the company beat EPS expectations and achieved nearly 40 basis points of gross margin improvement. A key brand partnership's AI-enabled product recommendations drove 6% net sales growth and 1% comparable sales growth. Two years of boardroom frustration ended.
CASE 8: Healthcare Retail — $15B Revenue Growth Through Privacy-First AI
Situation: A leading integrated healthcare and retail pharmacy company operating 8,600+ locations needed privacy and AI governance frameworks for a major healthcare technology transformation. Patient data, AI-powered personalization, and telehealth platforms all sat within the same governance gap. In healthcare retail, a single data incident affecting patient records is not a financial services fine. It is a patient trust crisis.
What Global Data Innovation’s Founder Did Prior to Starting the Company: Developed comprehensive privacy protection protocols and AI governance counseling for omnichannel healthcare delivery, including patient data privacy frameworks, AI safeguards, and digital best practices across pharmacy, telehealth, and retail touchpoints.
Outcome: Revenue grew by $15B+ over the engagement period. Over 100 million loyalty members were engaged through privacy-first personalized healthcare recommendations. AI-driven inventory optimization and prescription management were deployed with integrated privacy protections across all touchpoints. Patient trust held. Revenue grew.
TECHNOLOGY
CASE 9: $3.7 Trillion in Value Creation, 11-Year Governance Engagement
Situation: A global technology leader serving billions of users across cloud computing, productivity software, and AI platforms needed privacy, cybersecurity, and AI governance frameworks capable of operating at a scale, and a speed, no outside advisor had navigated before. The challenge was not writing a governance policy. It was building governance infrastructure that could keep pace with one of the fastest-moving technology companies in the world across 190+ countries and a regulatory environment that was changing every quarter.
What Global Data Innovation’s Founder Did Prior to Starting the Company: Provided comprehensive privacy, cyber, and AI governance advisory over an 11-year engagement. Work included privacy-by-design implementations, cybersecurity risk management frameworks, AI ethics and responsible AI principles, and regulatory compliance strategies that stayed ahead of the legislative curve in every major market.
Outcome: Revenue grew from $73.7 billion to $245 billion, a 232% increase over the engagement period. Market capitalization grew from approximately $300 billion to $3.7 trillion. The company's AI business surpassed $13 billion in annual run rate with 175% year-over-year growth. The governance foundation positioned the company as the recognized global leader in responsible AI development. Eleven years. Zero major privacy incidents. One of the most valuable companies in history.
A NOTE ON CONFIDENTIALITY
All case studies on this page are presented under attorney-client privilege and work product protection. Company names are withheld consistent with Global Data Innovation’s confidentiality obligations. Outcomes are drawn from publicly available financial reporting for the relevant periods. GDI does not disclose client identities without express written authorization.
The attorney-client privilege designation is not a formality. It is GDI's core structural differentiator. Work performed inside that privilege is protected from discovery, regulator subpoena, and competitor visibility in ways that no consulting engagement can match. That protection is part of what clients are engaging when they engage Global Data Innovation.
To discuss how our track record applies to your organization, contact Dominique Shelton Leipzig directly.
